Series date: 
04/01/2024 - 8:00am EDT to 12/31/2024 - 9:00am EST

COURSE DESCRIPTION:  

A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered neuro oncology care.

TARGET AUDIENCE:

Medical Oncologists, Radiation Oncologists, Neuro Cancer Surgeons, Neurologists, General Surgeons, Pathologists, Radiologists, Gynecologists, Pharmacists, Nurses, Social Workers, Radiologic Technologists, Patient Care Facilitators and all other personnel involved in the care of the neurological cancer patient.  

LEARNING OBJECTIVES:

  • Improve clinical decision making, clinical outcomes and patient experience via a multidisciplinary team approach. Group discussion includes prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies and supportive care services.
  • Develop a comprehensive treatment plan for brain and spine oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance.
     

FACULTY AND DISCLOSURES:

Timothy O’Connor, M.D., and Hina Saeed, M.D., directors of this educational activity, have no relevant financial relationships with ineligible companies* to disclose, and have indicated that the presentations or discussions will not include off-label or unapproved product usage.

Kendra Kent, M.S., R.N., CENP, CCRN, SCRN, CNRN, TCRN, planner of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1191880, by the Florida Boards of Medicine, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Techs, Respiratory Therapists, Occupational Therapists. Baptist Health South Florida CE Broker Provider #50-182.

image

American Board of Surgery - Maintenance of Certification (MOC) -   Accredited CME - Complex General Surgical Oncology and Neurocritical Care

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system. 

Series location: 
FL
United States

Sessions

Session Date
Marcus Neuroscience Institute Neuro Tumor Board 04/03/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 04/10/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 04/17/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 04/24/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 05/01/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 05/08/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 05/15/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 05/22/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 05/29/2024 - 8:00am to 9:00am EDT
Marcus Neuroscience Institute Neuro Tumor Board 06/05/2024 - 8:00am to 9:00am EDT

Pages